Sensei Biotherapeutics (STU:407) Ending Cash Position : €17.24 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sensei Biotherapeutics Ending Cash Position?

Sensei Biotherapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 was €17.24 Mil.

Sensei Biotherapeutics's quarterly Ending Cash Position increased from Mar. 2024 (€10.08 Mil) to Jun. 2024 (€11.05 Mil) and increased from Jun. 2024 (€11.05 Mil) to Sep. 2024 (€17.24 Mil).

Sensei Biotherapeutics's annual Ending Cash Position increased from Dec. 2021 (€6.34 Mil) to Dec. 2022 (€16.80 Mil) but then declined from Dec. 2022 (€16.80 Mil) to Dec. 2023 (€11.93 Mil).

Sensei Biotherapeutics Ending Cash Position Historical Data

The historical data trend for Sensei Biotherapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensei Biotherapeutics Ending Cash Position Chart

Sensei Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.23

13.64

6.34

16.80

11.93

Sensei Biotherapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															10.63	11.93	10.08	11.05	17.24

Sensei Biotherapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sensei Biotherapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16.318	+	-4.387
	=	11.93

Sensei Biotherapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.713	+	6.524
	=	17.24

Sensei Biotherapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sensei Biotherapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensei Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensei Biotherapeutics Inc (STU:407) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SNSE:USA

Address

1405 Research Boulevard, Suite 125, Rockville, MD, USA, 20850

Website

https://www.senseibio.com

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Sensei Biotherapeutics Headlines

No Headlines